Gilead Sciences | Marktkapitalisierung



Market Capitalization Veränderung Datum
AbbVie USD 327.88B 42.76B 2025-06
Agios Pharmaceuticals USD 1.93B 234M 2025-06
ALKERMES USD 4.72B 725M 2025-06
Alnylam Pharmaceuticals USD 42.52B 7.39B 2025-06
Amgen USD 150.13B 17.37B 2025-06
Biogen USD 18.41B 1.62B 2025-06
BioMarin Pharmaceutical USD 10.54B 3.01B 2025-06
Bristol-Myers Squibb USD 94.2B 29.9B 2025-06
Eli Lilly USD 738.79B 2.87B 2025-06
Gilead Sciences USD 137.91B 1.77B 2025-06
GlaxoSmithKline GBP 56.24B 4.11B 2025-06
Glaxosmithkline USD 82.21B 2.63B 2025-09
Incyte USD 13.18B 1.46B 2025-06
J&J USD 366.71B 32.94B 2025-06
Merck USD 198.77B 27.1B 2025-06
Moderna USD 10.67B 290M 2025-06
Neurocrine Biosciences USD 12.44B 1.5B 2025-06
Novartis CHF 256.18B 64.49B 2025-06
Pfizer USD 137.53B 6.19B 2025-06
PTC Therapeutics USD 3.87B 148M 2025-06
Regeneron Pharmaceuticals USD 55.87B 13.47B 2025-06
Sanofi EUR 100.06B 25.78B 2025-06
Sarepta Therapeutics USD 1.68B 4.51B 2025-06
United Therapeutics USD 12.96B 934M 2025-06
Vertex Pharmaceuticals USD 114.33B 10.31B 2025-06


Gilead Sciences Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.